Bernadette A M Heemskerk-Gerritsen
Overview
Explore the profile of Bernadette A M Heemskerk-Gerritsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beekman M, Terra L, Heemskerk-Gerritsen B, van der Aalst C, Roeters van Lennep J, van Beurden M, et al.
JACC CardioOncol
. 2025 Jan;
6(6):922-931.
PMID: 39801648
Background: Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, evidence...
2.
van Maldegem L, van der Zande J, van Werkhoven L, Ewing-Graham P, Heemskerk-Gerritsen B, van Doorn H
Acta Obstet Gynecol Scand
. 2024 May;
103(7):1283-1291.
PMID: 38695570
Introduction: Recurrent postmenopausal bleeding (PMB) occurs in 6%-25% of postmenopausal women who have experienced a previous episode of PMB. The question of whether recurrent PMB leads to a higher risk...
3.
Qu S, Timmermans A, Heemskerk-Gerritsen B, Trapman-Jansen A, Broeren-Foekens R, Prager-van der Smissen W, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201455
The ferritin-heavy chain (FTH1) is the catalytic subunit of the ferroxidase ferritin, which prevents oxidative DNA damage via intracellular iron storage. FTH1 was shown to be a prognostic marker for...
4.
Oztekin S, Hooning M, van Deurzen C, Dietvorst A, Drooger J, Kitzen J, et al.
Cancer
. 2023 Nov;
130(6):927-935.
PMID: 37985357
Background: Despite histological and molecular differences between invasive lobular carcinoma (ILC) and invasive carcinoma of no special type, according to national treatment guidelines no distinction is made regarding the use...
5.
Terra L, Heemskerk-Gerritsen B, Beekman M, Engelhardt E, Mourits M, van Doorn H, et al.
BJOG
. 2023 Jul;
131(1):99-108.
PMID: 37394722
Objective: To study the impact of premenopausal risk-reducing salpingo-oophorectomy (RRSO), compared with postmenopausal RRSO, on urinary incontinence (UI) ≥10 years later. Design: Cross-sectional study, nested in a nationwide cohort. Setting:...
6.
van Barele M, Akdeniz D, Heemskerk-Gerritsen B, Andrieu N, Nogues C, van Asperen C, et al.
J Natl Cancer Inst
. 2023 Jun;
115(11):1318-1328.
PMID: 37369040
Background: Radiation-induced secondary breast cancer (BC) may be a concern after radiation therapy (RT) for primary breast cancer (PBC), especially in young patients with germline (g)BRCA-associated BC who already have...
7.
Terra L, Lee Meeuw Kjoe P, Agelink van Rentergem J, Beekman M, Heemskerk-Gerritsen B, van Beurden M, et al.
BJOG
. 2023 Jan;
130(8):968-977.
PMID: 36715559
Objective: To examine the effect of a premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of ovarian cancer on objective and subjective cognition at least 10 years after RRSO....
8.
Terra L, Beekman M, Engelhardt E, Heemskerk-Gerritsen B, van Beurden M, Roeters van Lennep J, et al.
Am J Obstet Gynecol
. 2022 Nov;
228(4):440.e1-440.e20.
PMID: 36403862
Background: Women with a BRCA1/2 pathogenic variant are advised to undergo premenopausal risk-reducing salpingo-oophorectomy after completion of childbearing, to reduce their risk of ovarian cancer. Several studies reported less sexual...
9.
Heemskerk-Gerritsen B, Hollestelle A, van Asperen C, van den Beek I, van Driel W, van Engelen K, et al.
PLoS One
. 2022 Sep;
17(9):e0275015.
PMID: 36137114
Introduction: Germline BRCA1/2-associated epithelial ovarian cancer has been associated with better progression-free survival and overall survival than sporadic epithelial ovarian cancer, but conclusive data are lacking. Methods: We matched 389...
10.
Akdeniz D, Kramer I, van Deurzen C, Heemskerk-Gerritsen B, Schaapveld M, Westenend P, et al.
Cancer Med
. 2022 Sep;
12(3):3123-3133.
PMID: 36127572
Lobular primary breast cancer (PBC) histology has been proposed as a risk factor for contralateral breast cancer (CBC), but results have been inconsistent. We investigated CBC risk and the impact...